INMB Dec 2024 17.500 call
- GlobeNewswire
INmune Bio Inc. to Join Russell 3000® Index
Boca Raton, Florida, May 30, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1st, according to a preliminary list of additions posted Friday, May 24th. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as o
- Insider Monkey
INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript
INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript May 11, 2024 INmune Bio, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to the INmune Bio First Quarter 2024 Earnings Call. At the end of the […]
- Simply Wall St.
INmune Bio First Quarter 2024 Earnings: EPS Misses Expectations
INmune Bio ( NASDAQ:INMB ) First Quarter 2024 Results Key Financial Results Net loss: US$11.0m (loss widened by 69...
